Skip to content

Monday 9th December 2019 | Auckland

Angela Genge Photo

Angela Genge

Director of the Clinical Research Unit, Montreal Neurological Institute

Dr. Angela Genge, MD, FRCP(C) earned her medical degree from the Memorial University of Newfoundland. She completed her Canadian and American certifications in Internal Medicine and Neurology prior to completing a fellowship in neuromuscular diseases at McGill University. She recently completed an executive MBA through Lancaster University. Dr. Genge has been the Director of the Clinical Research Unit (CRU) at the Montreal Neurological Institute (the Neuro) since 2004. The CRU develops and executes over 100 clinical trials at any one time with an emphasis on ALS, rare neuromuscular diseases, multiple sclerosis, and primary brain tumors. These trials range from pharma/biotech-sponsored trials to investigator initiated trials supported by federal funds or private donors. Dr Genge’s expertise and groundbreaking work in the introduction of innovative therapies in the rare disease space has led her to be a sought after member of numerous advisory boards for companies developing therapies for these diseases. At the CRU Dr Genge manages a group of 50 coordinators, nurses and support staff and supports the principal investigators of the department of neurology and neurosurgery of McGill. On the clinical side Dr Genge is the director of the Neuro ALS clinical program and multidisciplinary clinic, and a Neuromuscular neurologist. Most recently Dr Genge has been part of the development of the Neuro Biobank (CBIGR).’’

Clinical Trial activity in ALS internationally: Where are we now?

Scroll To Top